Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Objectives:
Calotropin
(
CTP
), a natural product isolated from
Calotropis gigantea
, has been identified as a potential anticancer agent. In this study, we aimed to investigate the effect
CTP
on colorectal cancer and the role of Yes-associated protein (YAP) in
CTP
-inhibited cell proliferation.
Methods:
Cell viability and cell proliferation were detected by MTT and BrdU assay. Western blotting and immunofluorescence were performed to determine
CTP
-induced YAP dephosphorylation and nuclear localization. Western blotting, siRNA transfection and RT-PCR analysis were carried out to investigate the mechanisms of
CTP
-mediated YAP activation. The anti-tumor activities of
CTP
were observed in mice tumor models.
Results:
We demonstrated that
CTP
inhibits the proliferation of colorectal cancer cells both in vitro and in vivo. Moreover, we showed that
CTP
activates YAP in colorectal cancer cells. Mechanistically,
CTP
promotes LATS1 degradation via the ubiquitination/
proteasome
pathway, resulting in YAP dephosphorylation and nuclear localization, leading to induce YAP target genes expression in colorectal cancer cells. Inhibition of YAP activity enhances
CTP
-mediated inhibition of cell proliferation, suggesting that YAP plays a protective role in
CTP
-induced antiproliferative effect.
Conclusion:
Our results demonstrate that
CTP
markedly inhibits tumor growth and activates a protective role of YAP in colorectal cancer cells, indicating that combination of
CTP
and YAP targeting drugs may be a promising strategy for colorectal cancer treatment.
...
PMID:Calotropin activates YAP through downregulation of LATS1 in colorectal cancer cells. 3119 Aug 98